688139.SS Stock Analysis
68
Neutral
Based on Eyestock quantitative analysis, 688139.SS`s fundamental data and valuation indicate an investment grade of Neutral at the current time.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Moderate score
Upside
To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.
Greatly undervalued
Market cap $B
1.376
Dividend yield
2.43 %
Shares outstanding
449.89 B
Qingdao Haier Biomedical Co., Ltd. engages in the development of biotech products. The company is headquartered in Qingdao, Shandong and currently employs 2,078 full-time employees. The company went IPO on 2019-10-25. The firm's main businesses include: providing biomedical low-temperature storage solutions covering the whole temperature range for scenarios such as sample safety, drug and reagent safety, vaccine safety and blood safety, as well as automatic, intelligent and comprehensive upgrading based on user needs, and providing integrated solutions for Internet of Thing (IoT) scenarios covering a variety of biosafety products. The firm's products are sold to domestic and overseas markets.